Relmada Therapeutics, Inc. (RLMD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.8
Day's range
$7.41

Relmada Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/18/2026 11.06 M $76.89 M   52.19% 28.02%
05/15/2026 8.47 M $58.98 M   26.49% 21.47%
05/14/2026 6.26 M $43.00 M   53.25% 15.86%
VR ADVISER, LLC 05/15/2026 4.84 M $33.71 M   100.00% 12.27%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 4.76 M $33.15 M   11.55% 12.06%
ORBIMED ADVISORS LLC 05/15/2026 4.72 M $32.82 M   80.64% 11.95%
MARSHALL WACE, LLP 05/15/2026 4.48 M $31.19 M   40.50% 11.35%
MILLENNIUM MANAGEMENT LLC 05/15/2026 3.91 M $27.19 M   133.55% 9.90%
05/15/2026 3.08 M $21.41 M   100.00% 7.79%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 2.95 M $20.51 M   100.00% 7.47%
IKARIAN CAPITAL, LLC 05/15/2026 2.69 M $18.71 M   -12.38% 6.81%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 2.13 M $14.84 M   13.41% 5.40%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.41 M $9.85 M   100.00% 3.58%
BLACKROCK, INC. 05/13/2026 1.29 M $8.98 M   1.74% 3.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.01 M $7.04 M   162.10% 2.56%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 965.00 K $6.72 M   100.00% 2.44%
OPALEYE MANAGEMENT INC. 05/15/2026 935.00 K $6.51 M   0.00% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 848.68 K $5.91 M   -0.73% 2.15%
GREAT POINT PARTNERS LLC 05/15/2026 842.11 K $5.86 M   100.00% 2.13%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 842.11 K $5.86 M   100.00% 2.13%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 842.11 K $5.86 M   100.00% 2.13%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 842.11 K $5.86 M   100.00% 2.13%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 729.06 K $5.07 M   -12.72% 1.85%
CI PRIVATE WEALTH, LLC 05/15/2026 719.58 K $4.96 M   0.00% 1.82%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 712.54 K $4.96 M   35.28% 1.80%
GOLDMAN SACHS GROUP INC 05/15/2026 699.04 K $4.87 M   382.10% 1.77%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 653.33 K $4.55 M   320.07% 1.65%
COMMODORE CAPITAL LP 05/15/2026 633.90 K $4.41 M   100.00% 1.61%
STEMPOINT CAPITAL LP 05/18/2026 597.41 K $4.16 M   100.00% 1.51%
AMERIPRISE FINANCIAL INC 05/15/2026 533.26 K $3.71 M   -72.23% 1.35%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 504.82 K $3.51 M   169.41% 1.28%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 451.92 K $3.15 M   1,364.13% 1.14%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 450.00 K $3.13 M   100.00% 1.14%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 449.81 K $3.13 M   100.00% 1.14%
KNOTT DAVID M JR 05/14/2026 439.30 K $3.06 M   100.00% 1.11%
WOODLINE PARTNERS LP 05/15/2026 421.05 K $2.93 M   100.00% 1.07%
BIRCHVIEW CAPITAL, LP 05/15/2026 409.39 K $2.85 M   100.00% 1.04%
TWO SIGMA INVESTMENTS, LP 05/15/2026 408.10 K $2.84 M   -28.76% 1.03%
STATE STREET CORP 05/15/2026 357.04 K $2.48 M   11.29% 0.90%
PARSONS CAPITAL MANAGEMENT INC/RI 04/15/2026 352.50 K $2.45 M   34.03% 0.89%
05/14/2026 342.75 K $2.39 M   100.00% 0.87%
SEVEN GRAND MANAGERS, LLC 05/06/2026 315.79 K $2.20 M   100.00% 0.80%
ADVISORSHARES INVESTMENTS LLC 04/28/2026 295.87 K $2.06 M   -7.40% 0.75%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 281.80 K $1.96 M   497.03% 0.71%
EVERSEPT PARTNERS, LP 05/15/2026 277.90 K $1.93 M   100.00% 0.70%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 252.46 K $1.76 M   -53.92% 0.64%
DEUTSCHE BANK AG\ 05/06/2026 224.85 K $1.56 M   0.00% 0.57%
JANE STREET GROUP, LLC 05/12/2026 221.97 K $1.54 M   -18.13% 0.56%
ALLY BRIDGE GROUP (NY) LLC 05/18/2026 210.53 K $1.47 M   100.00% 0.53%
DIADEMA PARTNERS LP 05/15/2026 200.84 K $1.40 M   -48.42% 0.51%

Relmada Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 126 institutional investors and hedge funds held shares of Relmada Therapeutics Inc. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 11.06 M

VR Adviser, LLC: 4.84 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.76 M

ORBIMED ADVISORS LLC: 4.72 M

MARSHALL WACE, LLP: 4.48 M

MILLENNIUM MANAGEMENT LLC: 3.91 M

211.91% of Relmada Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 68.68 M shares in the last 24 months. This purchase volume represents approximately $492.43 M in transactions.